Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: which groups specifically benefit? Secondary analyses of a randomized controlled trial.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 10 11 2018
accepted: 22 02 2019
pubmed: 28 3 2019
medline: 23 11 2019
entrez: 28 3 2019
Statut: ppublish

Résumé

Stepped care (SC), consisting of watchful waiting, guided self-help, problem-solving therapy, and psychotherapy/medication is, compared to care-as-usual (CAU), effective in improving psychological distress. This study presents secondary analyses on subgroups of patients who might specifically benefit from watchful waiting, guided self-help, or the entire SC program. In this randomized controlled trial, head and neck and lung cancer patients with distress (n = 156) were randomized to SC or CAU. Univariate logistic regression analyses were performed to investigate baseline factors associated with recovery after watchful waiting and guided self-help. Potential moderators of the effectiveness of SC compared to CAU were investigated using linear mixed models. Patients without a psychiatric disorder, with better psychological outcomes (HADS: all scales) and better health-related quality of life (HRQOL) (EORTC QLQ-C30/H&N35: global QOL, all functioning, and several symptom domains) were more likely to recover after watchful waiting. Patients with better scores on distress, emotional functioning, and dyspnea were more likely to recover after guided self-help. Sex, time since treatment, anxiety or depressive disorder diagnosis, symptoms of anxiety, symptoms of depression, speech problems, and feeling ill at baseline moderated the efficacy of SC compared to CAU. Patients with distress but who are relatively doing well otherwise, benefit most from watchful waiting and guided self-help. The entire SC program is more effective in women, patients in the first year after treatment, patients with a higher level of distress or anxiety or depressive disorder, patients who are feeling ill, and patients with less speech problems. NTR1868.

Identifiants

pubmed: 30915569
doi: 10.1007/s00520-019-04714-3
pii: 10.1007/s00520-019-04714-3
pmc: PMC6825034
doi:

Substances chimiques

Psychotropic Drugs 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

4543-4553

Subventions

Organisme : ZonMw
ID : 300020012

Références

BMC Cancer. 2015 Apr 17;15:302
pubmed: 25903799
J Psychiatr Res. 1994 Jan-Feb;28(1):57-84
pubmed: 8064641
BMC Cancer. 2012 May 10;12:173
pubmed: 22574757
J Clin Oncol. 2013 Feb 20;31(6):782-93
pubmed: 23319686
Support Care Cancer. 2017 Nov;25(11):3385-3393
pubmed: 28593462
Ann Oncol. 2016 Sep;27(9):1754-60
pubmed: 27287209
Psychol Med. 1997 Mar;27(2):363-70
pubmed: 9089829
Ann Hematol. 2016 Jan;95(1):105-114
pubmed: 26420062
Psychooncology. 2015 Sep;24(9):1028-35
pubmed: 25631707
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
J Clin Oncol. 1999 Mar;17(3):1008-19
pubmed: 10071296
J Clin Oncol. 2017 Jan 20;35(3):314-324
pubmed: 27918712
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Eur J Cancer. 2002 Mar;38 Suppl 4:S125-33
pubmed: 11858978
J Behav Med. 2010 Feb;33(1):1-14
pubmed: 19784868
Support Care Cancer. 2015 Aug;23(8):2417-26
pubmed: 25612795
Psychooncology. 2018 Apr;27(4):1150-1161
pubmed: 29361206
J Natl Cancer Inst. 2009 Nov 4;101(21):1464-88
pubmed: 19826136
Radiother Oncol. 2014 Mar;110(3):422-8
pubmed: 24582144
Psychooncology. 2017 Oct;26(10):1675-1683
pubmed: 28665542
Eur J Cancer. 2005 Sep;41(14):2120-31
pubmed: 16182120
J Behav Med. 2012 Dec;35(6):658-73
pubmed: 22271329
Psychooncology. 2014 Feb;23(2):121-30
pubmed: 24105788
Eur J Cancer. 1994;30A(5):635-42
pubmed: 8080679
Psychol Med. 2015 Jan;45(2):231-46
pubmed: 25065653
Head Neck. 2016 Apr;38 Suppl 1:E1493-500
pubmed: 27111696

Auteurs

Femke Jansen (F)

Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

Birgit I Lissenberg-Witte (BI)

Department of Epidemiology and Biostatistics, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

Anna M H Krebber (AMH)

Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

Pim Cuijpers (P)

Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Remco de Bree (R)

UMC Utrecht Cancer Center, Utrecht, The Netherlands.

Annemarie Becker-Commissaris (A)

Department of Pulmonary Diseases, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

Egbert F Smit (EF)

Department of Pulmonary Diseases, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

Annemieke van Straten (A)

Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Guus M Eeckhout (GM)

Department of Psychiatry, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

Aartjan T F Beekman (ATF)

Department of Psychiatry, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

C René Leemans (CR)

Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

Irma M Verdonck-de Leeuw (IM)

Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. IM.Verdonck@vumc.nl.
Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands. IM.Verdonck@vumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH